Is It Time to Give TelaDoc a Health Check?
Just over 1,600 days since being added to the MyWallSt shortlist, it's time to take a look at Teladoc after its disastrous Q1 earnings call.
May 13, 2022

This article can be found in the MyWallSt App, alongside an audio companion. Sign up today for a free account and get access to dozens of expertly written articles and analyst opinion pieces every month.

It's been just over 1,600 days since we added Teladoc (NYSE: TDOC) to the MyWallSt shortlist and after a rollercoaster of a time, our total returns to date are basically break even. What happened to our one-time high-flier?

It was only two months ago that Teladoc's management came out with some very positive updated guidance -- possibly hoping to stem the tide of this relentless selloff in high-growth names. However, last week, the grim brutality of reality hit investors like a truck. This isn't, sadly, one of those cases where we can say the market has overreacted. Last week's report was, in a word, horrific.

What did Teladoc report in its most recent earnings call?

Revenue missed. That alone was going to be enough to panic investors. Even though it was a small miss, the market is taking no prisoners right now when it comes to non-profitable names. 

Here's what my colleague Emmet had to say when he saw the results:

"Looking at Teladoc's report, more or less all the numbers were in line with analyst expectations, which is good... or at least, not bad.

  • Revenue increased 25% to $565 million compared to Q1 2021.
  • Access fees revenue grew 29% to $491 million
  • Visit fee revenue grew 12% to $67.9 million.
  • U.S. Revenues grew 24% to $491.2 million
  • Revenue per user increased 20.5% to $2.52
  • International revenues grew 27% to $74.2 million.
  • Members grew 5% to 54.4 million

...all of that says that the business is doing what we hoped and expected."

In many ways he's right. The core telehealth business does seem to be performing quite well, if not quite as well as one would have hoped. However, the bad news hides right below those headline figures...

Top Ten Stocks To Buy Now
Commit to your future wealth today and join 1000s of subscribers receiving:
  • New stock picked every week out of 60,000 worldwide
  • Ten Foundational stocks to hold until 2034
  • A library of 60 stocks with analysis
  • 10 year Track record of performance
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Policy and Terms of Use.

The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.







This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.